These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9179738)

  • 1. Primary systemic amyloidosis with giant hepatomegaly and a swiftly progressive course.
    Mainenti PP; Petrelli G; Lamanda R; Amalfi G; Castiglione F
    J Clin Gastroenterol; 1997 Apr; 24(3):173-5. PubMed ID: 9179738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic amyloidosis presenting with severe intrahepatic cholestasis.
    Goenka MK; Bhasin DK; Vasisth RK; Dhawan S
    J Clin Gastroenterol; 1996 Sep; 23(2):134-6. PubMed ID: 8877643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Portal hypertension and intrahepatic cholestasis in primary amyloidosis.
    Çağlar E; Özbay G; Kalyon H; Sonsuz A
    Turk J Gastroenterol; 2014 Dec; 25 Suppl 1():258-9. PubMed ID: 25910329
    [No Abstract]   [Full Text] [Related]  

  • 4. Myeloma and severe cholestasis.
    Licht A; Maurer R; Oelz O
    Schweiz Med Wochenschr; 1999 Aug; 129(34):1201-4. PubMed ID: 10486860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Giant hepatomegaly and portal hypertension in an elderly patient with primary liver amyloidosis: an uncommon clinical occurrence.
    Basile G; Villari D; Nicita-Mauro V
    Eur Rev Med Pharmacol Sci; 2000; 4(1-2):47-50. PubMed ID: 11409189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Huge hepatomegaly, jaundice and portal hypertension due to amyloidosis of the liver.
    Melkebeke P; Vandepitte J; Hannon R; Fevery J
    Digestion; 1980; 20(5):351-7. PubMed ID: 7390060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary systemic amyloidosis with giant hepatomegaly and portal hypertension: a case report and a review of the literature.
    Serra L; Poppi MC; Criscuolo M; Zandomeneghi R
    Ital J Gastroenterol; 1993 Oct; 25(8):435-8. PubMed ID: 8286779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatomegaly and cholestasis as primary clinical manifestations of an AL-kappa amyloidosis.
    Mohr A; Miehlke S; Klauck S; Röcken C; Malfertheiner P
    Eur J Gastroenterol Hepatol; 1999 Aug; 11(8):921-5. PubMed ID: 10514129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary amyloidosis presenting as intrahepatic cholestasis.
    Bandyopadhyay SK; Bandyopadhyay R; Dutta A
    Indian J Pathol Microbiol; 2006 Oct; 49(4):557-9. PubMed ID: 17183853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe intrahepatic cholestasis, erythrocytosis and hypoglycemia: unusual presenting features of systemic AL amyloidosis.
    Ferreira S; Baldaia C; Fatela N; Ramalho F; Costa MA; Brito D; Esteves G; Monteiro E
    Scand J Gastroenterol; 2008 Mar; 43(3):375-9. PubMed ID: 18938770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance imaging with liver-specific contrast agent in primary amyloidosis and intrahepatic cholestasis.
    Møller JM; Santoni-Rugiu E; Chabanova E; Løgager V; Hansen AB; Thomsen HS
    Acta Radiol; 2007 Mar; 48(2):145-9. PubMed ID: 17354133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnostic difficulties in hepatic amyloidosis--clinical analysis and autopsy data of 3 cases].
    Dabrowska E; Jabłońska-Kaszewska I; Sworczak K; Sliwińska I
    Pol Arch Med Wewn; 1990 Sep; 84(3):176-81. PubMed ID: 2267176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of prominent hepatic cholestasis developing to hepatic failure in lambda-AL amyloidosis.
    Dohmen K; Nagano M; Iwakiri R; Yamano Y; Kikuchi Y; Mizoguchi M; Iwata Y; Mori Y; Ishibashi H
    Gastroenterol Jpn; 1991 Jun; 26(3):376-81. PubMed ID: 1889693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hepatic amyloidosis as cause of severe intrahepatic cholestasis].
    Gavilán JC; Bermúdez FJ; Márquez A; Sánchez-Carrillo JJ; González-Santos P
    An Med Interna; 2003 Jan; 20(1):25-7. PubMed ID: 12666305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Primary amyloidosis of the gastrointestinal tract and liver--two case reports].
    Halm U; Berr F; Eggers E; Wohlgemuth B; Mössner J
    Z Gastroenterol; 1997 Feb; 35(2):131-7. PubMed ID: 9163226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Two cases of systemic amyloidosis presenting with abnormalities in liver function tests].
    Park JH; Park CK; Yun YM; Hyun DW; Kim ES; Park SY; Jo CM; Tak WY; Kweon YO; Kim SK; Choi YW
    Korean J Gastroenterol; 2003 Oct; 42(4):341-6. PubMed ID: 14634355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary amyloidosis presenting with cholestasis and hyperkinetic portal hypertension.
    Culafić D; Perisić M; Boricić I; Culafić-Vojinović V; Vukcević M
    J Gastrointestin Liver Dis; 2007 Jun; 16(2):201-4. PubMed ID: 17592572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe recurrent intrahepatic cholestasis in systemic AL amyloidosis without evident liver involvement. Unexplained hepatic toxicity or a case of misdiagnosed liver amyloidosis?
    Paudice N; Farsetti S; Caroti L; Ciuti G; Tempestini A; Perfetto F; Bergesio F
    Amyloid; 2011 Jun; 18 Suppl 1():142-4. PubMed ID: 21838465
    [No Abstract]   [Full Text] [Related]  

  • 19. Different morphologic aspects and clinical features in massive hepatic amyloidosis.
    Melato M; Manconi R; Magris D; Morassi P; Benussi DG; Tiribelli C
    Digestion; 1984; 29(3):138-45. PubMed ID: 6745505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholestasis and renal failure in a patient with secondary amyloidosis.
    Unsal C; Paydaş S; Gönlüşen G
    Ren Fail; 2002 Nov; 24(6):863-6. PubMed ID: 12472208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.